- Home
- IOSP vs DYN Comparison
IOSP vs DYN Comparison
Compare IOSP & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOSP
- DYN
- Stock Information
- Founded
- IOSP 1938
- DYN 1984
- Country
- IOSP United States
- DYN United States
- Employees
- IOSP N/A
- DYN N/A
- Industry
- IOSP Major Chemicals
- DYN Medicinal Chemicals and Botanical Products
- Sector
- IOSP Industrials
- DYN Health Care
- Exchange
- IOSP Nasdaq
- DYN Nasdaq
- Market Cap
- IOSP 2.1B
- DYN 1.9B
- IPO Year
- IOSP 1998
- DYN 2020
- Fundamental
- Price
- IOSP $81.67
- DYN $13.40
- Analyst Decision
- IOSP Strong Buy
- DYN Strong Buy
- Analyst Count
- IOSP 1
- DYN 14
- Target Price
- IOSP $155.00
- DYN $34.93
- AVG Volume (30 Days)
- IOSP 167.3K
- DYN 2.2M
- Earning Date
- IOSP 11-04-2025
- DYN 11-11-2025
- Dividend Yield
- IOSP 2.05%
- DYN N/A
- EPS Growth
- IOSP N/A
- DYN N/A
- EPS
- IOSP 0.77
- DYN N/A
- Revenue
- IOSP $1,790,700,000.00
- DYN N/A
- Revenue This Year
- IOSP $0.25
- DYN N/A
- Revenue Next Year
- IOSP $7.46
- DYN N/A
- P/E Ratio
- IOSP $106.25
- DYN N/A
- Revenue Growth
- IOSP N/A
- DYN N/A
- 52 Week Low
- IOSP $74.10
- DYN $6.36
- 52 Week High
- IOSP $128.35
- DYN $37.08
- Technical
- Relative Strength Index (RSI)
- IOSP 41.68
- DYN 59.74
- Support Level
- IOSP $79.77
- DYN $12.65
- Resistance Level
- IOSP $82.97
- DYN $13.60
- Average True Range (ATR)
- IOSP 1.78
- DYN 0.64
- MACD
- IOSP -0.57
- DYN -0.13
- Stochastic Oscillator
- IOSP 21.47
- DYN 44.93
About IOSP Innospec Inc.
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Fuel Specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field service providers in the extraction of oil and gas. The Performance Chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.